Press briefing with Todd D. Robinson, Assistant Secretary of State for International Narcotics and Law Enforcement Affairs

MODERATOR:  Greetings to everyone from the U.S. Department of State’s Media Hub of the Americas in Miami, Florida.  I would like to welcome our participants who have dialed in from the United States and across the region.  This is an on-the-record press briefing with the Assistant Secretary of State for International Narcotics and Law Enforcement Affairs Todd D. Robinson. 

Assistant Secretary Robinson will discuss outcomes from Friday’s virtual ministerial to launch a Global Coalition to Address Synthetic Drug Threats as well as next steps for the global coalition.  This coalition seeks to unite countries worldwide in a concerted effort to prevent the illicit manufacture and trafficking of synthetic drugs, identify emerging drug trends, and respond effectively to their public health impacts. 

As a reminder, today’s briefing is on the record.  And with that, I will turn it over to Assistant Secretary Robinson. 

ASSISTANT SECRETARY ROBINSON:  Thank you for joining this call today and for the opportunity to discuss the collective efforts we have undertaken to confront the important issue of synthetic drugs. 

Last Friday, as you know, Secretary Blinken hosted a virtual ministerial to launch a Global Coalition to Address Synthetic Drug Threats.  Nearly 100 countries and international organizations participated in the launch, underscoring the shared concern about this public health and national security threat.  The coalition aims to unite countries worldwide in a concerted effort to combat the illicit manufacture and trafficking of synthetic drugs.  Together, we hope to strengthen efforts to prevent the production and trafficking of illicit synthetic drugs, identify emerging synthetic drug trends and use patterns, and promote efforts to respond effectively to the public health impacts they impose. 

Participants at the ministerial underscored the importance of sharing data and increasing efforts to mitigate the health impact of synthetic drug use.  As you all already know, synthetic drugs such as fentanyl and methamphetamine pose a grave risk to the health and security of our citizens here in the United States.  The consequences of these drugs are devastating as evidenced by the alarming statistics. 

In 2022, the CDC estimated that nearly 110,000 Americans lost their lives to drug overdoses.  Recognizing the gravity of this situation, the Biden administration is fully committed to preventing drug use and minimizing its negative impact.  We understand the importance of connecting individuals to treatment and supporting the more than 20 million Americans in recovery.  President Biden’s National Drug Control Strategy has allocated a substantial $24 billion dollars in this fiscal year to strengthen drug-related public health interventions.  These measures not only safeguard the health of our citizens, but also exemplify our dedication at home as we look to other nations to also take action. 

It is vital to note that these dangers are not limited to the United States.  More countries than ever are facing an increasing threat from synthetic drugs like tramadol, Captagon, MDMA, and Ketamine.  Criminals are constantly innovating to create new synthetic drugs, adjusting formulas to avoid international controls and domestic regulations, and creating new demand.   

One staggering number to note:  Over the past decade, more than 1,100 new synthetic drugs were detected and reported by the United Nations.  Through the Global Coalition to Address Synthetic Drug Threats, we are harnessing international cooperation and shared knowledge to tackle this crisis head on.  By working together, we can more effectively disrupt the illicit synthetic drug supply chains, enhance our ability to identify and respond to emerging threats, and protect the lives and well-being of our own citizens and of people around the world. 

The United States has already been working with partners like Mexico, Canada, and other countries to drive urgent global action to disrupt the synthetic drug trade from beginning to end.  We are engaging with countries such as India to strengthen our partnerships on securing pharmaceutical and chemical supply chains to prevent criminal diversion of dual-use precursor chemicals, and we remain committed to engaging with the PRC to address the threat illicit synthetic drugs pose to our countries.  The Department of State also works within the UN, the Organization of American States, the G7, G20, and other organizations to improve the abilities of our countries to detect and disrupt the illicit manufacturing, diversion, and trafficking of precursor chemicals and finished drugs.   

We have more important work to do, so in closing, let me express my gratitude to our international partners who have already joined us in this crucial endeavor.  The fight against synthetic drugs requires a global response, and we are confident that our collective efforts will yield significant results.  Together, we can create a safer and healthier future for our citizens and generations to come.   

Thank you, and I look forward to your questions.   

MODERATOR:  Thank you so much, Assistant Secretary.  We will now begin the question-and-answer portion of today’s briefing.  For those on the English line asking questions, please limit yourself to one question related to the topic of today’s briefing.  If you submitted your question in advance, I have incorporated the question into the queue.  

Our first question today we received from Daniel – from Jim Carson of La Jornada in Mexico:  “What specific will be new out of this declaration?  Are you setting up a FinCEN-type structure to share information, do evaluations, and a secretariat, or is it simply a reiteration of past commitments without any specific additional actions?”   

ASSISTANT SECRETARY ROBINSON:  Great question.  The first thing I would say is we are – we are building on what we have done in the past and what has been done by other countries in the past.  The coalition is intended to be an inclusive forum for sharing best practices and identifying areas for collaboration to improve the global response to public health and security threats posed by synthetic drugs.  We ask that countries commit to working collaboratively with other coalition member countries at both political and technical levels to develop a joint framework for addressing synthetic drugs and develop actions in line with that framework.  Thanks.   

MODERATOR:  Thank you.  We received a question from journalist Fernando Morales from Red Salvadoreña de Medios in El Salvador: “El Salvador is a corridor for the transit of synthetic drugs like fentanyl.  How is work being done to prevent the trafficking of these narcotics?”   

ASSISTANT SECRETARY ROBINSON:  I’m sorry.  Could you say that again?  

MODERATOR:  Absolutely, Assistant Secretary.  “El Salvador is a corridor for the transit of synthetic drugs like fentanyl.  How is work being done to prevent the trafficking of these narcotics?” 

ASSISTANT SECRETARY ROBINSON:  Great question.  As our correspondent will note, the United States Government on several different levels is working with members of the civilian security forces in El Salvador and throughout the region – El Salvador, Guatemala, and Honduras – on things like investigations, going after the trafficking networks.  We have experts on the ground from DEA and the Department of Justice.   

We also work on training.  As the correspondent will note, there is an International Law Enforcement Academy hosted by the Government of El Salvador where we can do training for police and prosecutors in the region on different techniques and modernized techniques for going after these networks.  So those are ways that we are – those are ways that we are trying to get after these – shut down these corridors.   

MODERATOR:  Thank you, Assistant Secretary.  The next question will go to Jesús Esquivel from Proceso Magazine in Mexico.  Jesús, please unmute yourself.   

QUESTION:  Hello.  Can you hear me?   

MODERATOR:  Yes.  Please ask your question.  —    

QUESTION:  Okay.  Yes.  Under Secretary, there has always been the accusations that the Mexican cartels are responsible for all the synthetic drugs in the United States, but as you probably know, the domestic cartels in the U.S. are also responsible for the distributions and sale of these drugs.   

My question to you is:  What exactly or when exactly the U.S. Government for the first time is going to be exposing the domestic cartels in this problem and in the United States?  And also, if you think the accusations as – members of the U.S. Congress made to Mexico and threats that they probably going to invade Mexico to stop the drug trafficking, it will help in this global coalition in the case of – specifically of Mexico to cooperate with the U.S. Government?   

ASSISTANT SECRETARY ROBINSON:  Thank you, Jesús.  Both good questions.  Look, first of all, I would – I would not exactly support the premise of your question.  We have never said that all of the fentanyl or synthetic opioids that are coming to the United States are coming from Mexico.  We know that this is a global – a global effort by cartels from different regions around the world, including criminals in the United States.  I don’t think the FBI or the Department of Justice or our local law enforcement authorities have been shy about exposing the criminal networks in the United States that are trafficking in these drugs.  I think they will continue to publicly expose them when available.  So that’s thing number one. 

Thing number two, we have – the United States has an excellent relationship with our counterparts in Mexico.  We are both working very close to go after the networks in Mexico, to increase our cooperation on both sides of our southwest border, your northern border.  And we are working together internationally to share our experiences with working together with other countries around the world.  I’m very proud of our relationship with our Mexican counterparts, and we’re going to continue to call on them as they call on us to work together to do more to stop – to stop this global trafficking of synthetic drugs. 

MODERATOR:  Thank you, Assistant Secretary Robison.  The next question will go to Adyr Corral from El Sol de Mexico.  Adyr, please unmute yourself.  Go ahead.  Adyr, can you hear us?   

Okay, unfortunately we’re going to have to move on.  I see we have a submitted question in our Q&A from Brendan O’Boyle from Reuters in Mexico City: “Thank you, Ambassador.  Within the coalition, where is there concern about fentanyl’s short-term spread geographically?  In Mexico, some experts have sounded alarm about fentanyl spreading in drug supply domestically, though data is scarce.  Have coalition partners in Mexico recognized domestic spread?” 

ASSISTANT SECRETARY ROBINSON:  I’m sorry, can you repeat that question again? 

MODERATOR:  Sure, sir.  “Thank you, Ambassador.  Within the coalition, where is there concern about fentanyl’s short-term spread geographically?  In Mexico, some experts have sounded the alarm about fentanyl spreading in the drug supply domestically, though data is scarce.  Have coalition partners in Mexico recognized domestic spread?” 

ASSISTANT SECRETARY ROBINSON:  The short answer is I believe the Government of Mexico has recognized the short-term spread of synthetic opioids.  We are – and – but there’s a very good relationship between our Office of National Drug Control Policy and the secretary for Health in Mexico.  They are working very closely together on campaigns to raise awareness about synthetic opioids and what can be done to avoid falling into – into that addiction.  So we feel like we have a burgeoning story to tell, a better story to tell as we go forward on our cooperation on the messaging against the domestic – in Mexico, the domestic spread of the – and growth of the use of synthetic opioids. 

MODERATOR:  Thank you, Assistant Secretary.  I’m told we’ve resolved the microphone issues with Adyr Corral, so we’ll go back to Adyr Corral from El Sol de Mexico.  Please unmute yourself. 

QUESTION:  Hi.  You can hear me? 

ASSISTANT SECRETARY ROBINSON:  Yes. 

MODERATOR:  We can hear you. 

QUESTION:  Ah, thank you very much.  Sorry for the problems.  I would like to ask the assistant secretary for a comment on the initiative to designate the fentanyl as a weapon of mass destruction in Congress.  How about that, Assistant Secretary? 

ASSISTANT SECRETARY ROBINSON:  Thank you, great question.  We have currently – the Department of Justice, DEA, FBI, Department of State – we feel like we have the authorities necessary to go after the networks that are trafficking in these drugs.  At the moment, we don’t see that classifying fentanyl as a weapon of mass destruction will give us any more authority than we already have to try to stop its trafficking.  So we feel pretty comfortable that we’re in a good place in terms of having the tools necessary to go after the drug and to go after the networks that are trafficking the drugs.  

QUESTION:  Thank you very much.  

MODERATOR:  Thank you, Assistant Secretary.  The next question was submitted in advance from Juan Silva from W Radio in Colombia:  “How do you assess the current situation in Colombia in terms of the fight against drugs?”  

ASSISTANT SECRETARY ROBINSON:  Well, as the correspondent, as Juan will know, we have a very long, very strong, very deep relationship with Colombia and Colombia’s security forces that has developed over a number of years.  We feel like we are – we have developed into great partners.  Colombia has become a net exporter of security globally, and that is in large part due to the very strong relationship that has developed with the United States.   

Today we continue in that effort.  There are areas where we are hoping to start working – new areas where we are starting to – we want to begin working with the Petro government, and we are in constant conversation with Petro and his team to figure out how we can best help them bring greater security and safety to communities in Colombia, and by doing so, help shut down the networks that are trafficking drugs north to the United States.  Thanks.  

MODERATOR:  Thank you, Assistant Secretary.   

Our next question we received from Eduard Ribas from EFE:  “What responsibility does China have on the trafficking of fentanyl precursors?  How can this coalition be successful without Chinese participation?”  

ASSISTANT SECRETARY ROBINSON:  Well, I would say the – we know good things happen when China is involved in conversations like this.  You will recall in 2019 the Chinese Government scheduled fentanyl and made it much harder to get out of the country directly and be shipped directly to other countries.  And when they did that, the trafficking of fentanyl itself in the United States from China went to almost zero.  

So we think that there’s a lot more that can be done by the PRC in terms of greater monitoring and labeling and information-sharing on the precursor chemicals that are leaving the PRC, and they – we invited them to join the coalition.  We expect at some point that they will take us up on our invitation because they want to be responsible, a responsible country in this effort.  And we all know that they play – that there are companies in China that play an important role in the distribution of the precursor chemicals that go into making these drugs.  Over.  

MODERATOR:  Thank you, Assistant Secretary.  We have time for about two more questions.  One was submitted in advance from a journalist in Guyana regarding CARICOM, Denis Chabrol from Demarara Waves Online News:  “How badly are Caribbean Community (CARICOM) nations affected by synthetic drugs?”  

ASSISTANT SECRETARY ROBINSON:  Thank you.  Again, this is a – that’s a great question.  I would say although we haven’t seen significant production in the Caribbean, it’s important to note that criminal chemists can easily synthesize fentanyl almost anywhere.  The Global Coalition to Address Synthetic Drug Threats will provide a foundation for developing and implementing effective, practical solutions to prevent the illicit manufacture and trafficking of synthetic drugs.  It will help detect emerging drug threats, and we hope it will help respond to the – to their public health impacts.  Over. 

MODERATOR:  Thank you.  I see in the chat the journalist had added:  “What do we expect from CARICOM and what assistance the U.S. can provide?” 

ASSISTANT SECRETARY ROBINSON:  Well, actually, I would turn it around.  The question should be:  What more can CARICOM countries do?  And I think, again, when we talk about things like exchanging information, when we talk about things like making sure that they are getting access, making sure their communities are getting access to the antidotes for overdoses, making sure that they are reporting to the international organizations that are collecting information that everybody else can use – those are the things that that we would hope we could get from countries that are involved in the global coalition.  And the United States and the international community will continue to help with training and equipping those police forces and prosecutors that are working on this issue.  Over. 

MODERATOR:  Thank you, Assistant Secretary.  We had a question from Martin Villena from Andina News Agency in Peru:  “Concerning the Global Coalition to Address Synthetic Drug Threats, does its launch also mean strengthening even more relations with countries such as Peru and Colombia, which face the issue and the related problems concerning cocaine productions in their territories?” 

ASSISTANT SECRETARY ROBINSON:  Well, we’re always working to strengthening – strengthening the relationship with our good friends in Peru and Colombia.  But in fact, again, we will – what the establishment of this coalition is looking to do is to have our friends from Peru and Colombia share their experiences with other countries around the world and help other countries who don’t have the expertise that our countries do, help them address the issues in their countries.  We have great relationships with our partners in Peru and Colombia; I don’t expect that will change.  But we will – in the establishment of this coalition, we will be asking them to do more to help on a global level.  Over.   

MODERATOR:  Thank you, Assistant Secretary.  We received a question from Carrie Kahn with NPR:  “How do proposals from some Republicans in the United States urging military intervention to stop fentanyl trafficking in Mexico affect your plans to enlist global partners?” 

ASSISTANT SECRETARY ROBINSON:  Well, I would say we’re going to let Congress – the Senate and the House – develop and debate their own ideas.  We are going to – I am focused on working with our civilian security partners globally, making sure that they have the training, the equipment, the strategies; making sure they have access to the expertise necessary to focus on what is our responsibility, which is providing civilian security to our communities, both in the United States and around and world. 

MODERATOR:  Thank you, Assistant Secretary.  I believe we’ve gone through all the questions that we had today, so that will conclude today’s briefing.  I wanted to thank you for joining us today, as well as all of the journalists on the line for their questions.  If you have any follow-up questions about today’s briefing, you may contact the Miami Media Hub at MiamiHub@state.gov.  An English recording and transcript will be available for this briefing, as well as transcripts in Spanish and Brazilian Portuguese.  Thank you so much and have a good day. 

ASSISTANT SECRETARY ROBINSON:  Thanks.  Thanks, everybody.